XyloCor Therapeutics
-
King of Prussia’s XyloCor Therapeutics Raises $67.5 Million to Advance Gene Therapy
King of Prussia-based XyloCor Therapeutics has managed to raise $67.5 million in Series B financing to advance its gene therapy…
-
3 Life Sciences Companies Make Long-Term Commitments to Nearby Chester County
As the pandemic-related business slumps abate, three life sciences companies made long-term commitments to the region. They’ve each signed leases…
Founding Partners
Advertisement
Affiliate Partners
Community Partners
